Page results
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
File results
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0709 - Number of dilation and curettage operations for miscarriages 2019-2024
-
FOI/2024/0712 - Occupational health services, spend/ in-house/ outsourced 2021/22-2023/24
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0719 - Tenders and prices for interpretation services
-
FOI/2024/0720 - Motion picture licensing corporation
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology